LncRNA LINC01857 Drives Pancreatic Adenocarcinoma Progression Via Modulating MiR-19a-3p/SMOC2

Overview

Journal Clinics (Sao Paulo)

Publisher Elsevier

Specialty General Medicine

Date 2022 Jun 6

PMID 35662010

Authors

Yeting Lu

Dongjian Ying

Yuan Tian

Yi Ruan

Gong Cheng

Kaiji Lv

Xinhua Zhou

Shuo Han

Affiliations

Soon will be listed here.

Abstract

Objectives: Emerging evidence has demonstrated that LINC01857 exerts a pivotal function in many cancers. However, its function in Pancreatic Ductal Adenocarcinoma (PDAC) still remains unclear. This study was designed to investigate the regulatory character of LINC01857 in PDAC.

Methods: Bioinformatic tools and databases were used to seek potential miRNAs and mRNAs. Gene expression was evaluated by Reverse Transcription quantitative real-time Polymerase Chain Reaction (RT-qPCR), and western blot was used for protein level detection. A subcellular fraction assay was done to ascertain the location of LINC01857 in PANC-1 and BxPC-3 human pancreatic cancer cells. CCK-8, EdU, wound healing and Transwell assays were performed to inquire into the influence of LINC01857, and SPARC -related Modular Calcium-binding protein-2 (SMOC2) on cell viability, proliferation, migration, and invasion, respectively. The interaction between LINC01857 and its downstream genes was explored by RNA immunoprecipitation and luciferase reporter assays.

Results: LINC01857 levels were significantly elevated in PDAC. Knockdown of LINC01857 significantly restrained the proliferation, migration, invasion, and Epithelial-Mesenchymal Transition (EMT) process of PDAC cells. MiR-19a-3p was a downstream target of LINC01857, and miR-19a-3p levels were significantly decreased in PDAC cells. In addition, SMOC2 expression had a negative correlation with that of miR-19a-3p, and SMOC2 was a downstream target of miR-19a-3p. Furthermore, SMOC2 upregulation partially abolished the inhibitive influence of LINC01857 downregulation on cell proliferation, migration, invasion, and the EMT process.

Conclusion: LINC01857 promotes malignant phenotypes of PDAC cells via upregulation of SMOC2 by interacting with miR-19a-3p.

Citing Articles

LINC01857 promotes cell proliferation and migration while dampening cell apoptosis in pancreatic cancer by upregulating CDC42EP3 via miR-450b-5p.

Zhang J, Shen Y, Ma D, Li Z, Zhang Z, Jin W Heliyon. 2024; 10(21):e38427.

PMID: 39524859 PMC: 11547965. DOI: 10.1016/j.heliyon.2024.e38427.

Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy.

Zabeti Touchaei A, Vahidi S, Samadani A Med Oncol. 2023; 41(1):21.

PMID: 38112798 DOI: 10.1007/s12032-023-02251-y.

H19 encourages aerobic glycolysis and cell growth in gastric cancer cells through the axis of microRNA-19a-3p and phosphoglycerate kinase 1.

Chen S, Wang H, Xu P, Dang S, Tang Y Sci Rep. 2023; 13(1):17181.

PMID: 37821504 PMC: 10567772. DOI: 10.1038/s41598-023-43744-0.

References

Peeters T, Monteagudo S, Tylzanowski P, Luyten F, Lories R, Cailotto F . SMOC2 inhibits calcification of osteoprogenitor and endothelial cells. PLoS One. 2018; 13(6):e0198104. PMC: 5999237. DOI: 10.1371/journal.pone.0198104. View

Quinn J, Chang H . Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2015; 17(1):47-62. DOI: 10.1038/nrg.2015.10. View

Xu F, Wu H, Xiong J, Peng T . Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation. Front Mol Biosci. 2021; 8:645365. PMC: 8100451. DOI: 10.3389/fmolb.2021.645365. View

Hu G, Liu N, Wang H, Wang Y, Guo Z . LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR-1281/TRIM65 axis. J Cell Physiol. 2019; 234(12):22009-22016. DOI: 10.1002/jcp.28763. View

Zhou R, Zhang E, Sun Q, Ye Z, Liu J, Zhou D . Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer. 2019; 19(1):779. PMC: 6686570. DOI: 10.1186/s12885-019-5983-8. View

Tian S, Guo X, Yu C, Sun C, Jiang J . miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1. Oncotarget. 2017; 8(7):11071-11082. PMC: 5355247. DOI: 10.18632/oncotarget.14360. View

Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C . Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol Cancer. 2019; 18(1):3. PMC: 6323810. DOI: 10.1186/s12943-018-0931-9. View

Goral V . Pancreatic Cancer: Pathogenesis and Diagnosis. Asian Pac J Cancer Prev. 2015; 16(14):5619-24. DOI: 10.7314/apjcp.2015.16.14.5619. View

Su J, Kuai J, Li Y . Smoc2 potentiates proliferation of hepatocellular carcinoma cells promotion of cell cycle progression. World J Gastroenterol. 2016; 22(45):10053-10063. PMC: 5143752. DOI: 10.3748/wjg.v22.i45.10053. View

10.

Ye Y, Shen A, Liu A . Long non-coding RNA H19 and cancer: A competing endogenous RNA. Bull Cancer. 2019; 106(12):1152-1159. DOI: 10.1016/j.bulcan.2019.08.011. View

11.

Zhang B, Liu Y, Zhang J . Silencing of miR-19a-3p enhances osteosarcoma cells chemosensitivity by elevating the expression of tumor suppressor PTEN. Oncol Lett. 2019; 17(1):414-421. PMC: 6313165. DOI: 10.3892/ol.2018.9592. View

12.

Ilic M, Ilic I . Epidemiology of pancreatic cancer. World J Gastroenterol. 2016; 22(44):9694-9705. PMC: 5124974. DOI: 10.3748/wjg.v22.i44.9694. View

13.

Wu X, Sui Z, Zhang H, Wang Y, Yu Z . Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. Front Oncol. 2020; 10:554759. PMC: 7523091. DOI: 10.3389/fonc.2020.554759. View

14.

Liu H, Li H, Jin L, Li G, Hu S, Ning C . Long Noncoding RNA GAS5 Suppresses 3T3-L1 Cells Adipogenesis Through miR-21a-5p/PTEN Signal Pathway. DNA Cell Biol. 2018; 37(9):767-777. DOI: 10.1089/dna.2018.4264. View

15.

Kabekkodu S, Shukla V, Varghese V, D Souza J, Chakrabarty S, Satyamoorthy K . Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018; 93(4):1955-1986. DOI: 10.1111/brv.12428. View

16.

Hong C, Lishan W, Peng X, Zhengqing L, Yang Y, Fangfang H . Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC. J Cancer. 2022; 13(1):34-50. PMC: 8692684. DOI: 10.7150/jca.62927. View

17.

Kim H, Choi J, Lee J, Kang J, Myung J, Kim W . Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance. Sci Rep. 2020; 10(1):4853. PMC: 7078233. DOI: 10.1038/s41598-020-61828-z. View

18.

Vannahme C, Gosling S, Paulsson M, Maurer P, Hartmann U . Characterization of SMOC-2, a modular extracellular calcium-binding protein. Biochem J. 2003; 373(Pt 3):805-14. PMC: 1223551. DOI: 10.1042/BJ20030532. View

19.

Li Q, Li B, Lu C, Wang J, Gao M, Gao W . LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma. Cancer Gene Ther. 2020; 28(9):1046-1057. DOI: 10.1038/s41417-020-00267-4. View

20.

Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View